HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Afargan Selected Research

PTR 3173

8/2001A novel somatostatin analogue prevents early renal complications in the nonobese diabetic mouse.
1/2001Novel long-acting somatostatin analog with endocrine selectivity: potent suppression of growth hormone but not of insulin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Afargan Research Topics

Disease

1Albuminuria
08/2001
1Diabetic Nephropathies (Diabetic Nephropathy)
08/2001
1Hypertrophy
08/2001
1Carcinoid Tumor (Carcinoid)
01/2001

Drug/Important Bio-Agent (IBA)

2PTR 3173IBA
08/2001 - 01/2001
1CreatinineIBA
08/2001
1Insulin (Novolin)FDA Link
08/2001
1Octreotide (Sandostatin)FDA LinkGeneric
01/2001
1ColforsinIBA
01/2001